Evidence map›Paper›PMID 30555566›Full record

ArticleTheranostics2018

miR-125a-5p ameliorates hepatic glycolipid metabolism disorder in type 2 diabetes mellitus through targeting of STAT3.

Lina Xu, Yue Li, Lianhong Yin, Yan Qi, Huijun Sun, Pengyuan Sun, Ming Xu, Zeyao Tang, Jinyong Peng

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 157 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Lina XuCollege of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.
Yue LiCollege of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.
Lianhong YinCollege of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.
Yan QiCollege of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.
Huijun SunCollege of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.
Pengyuan SunCollege of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.
Ming XuCollege of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.
Zeyao TangCollege of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.
Jinyong PengCollege of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.
Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycolipid metabolic disorder is an important cause for the development of type 2 diabetes mellitus (T2DM). Clarification of the molecular mechanism of metabolic disorder and exploration of drug targets are crucial for the treatment of T2DM.

Indexed as

AnimalsBlotting, WesternDiabetes Mellitus, Type 2Glucose Tolerance TestGlycolipidsLipid MetabolismLipogenesisLiverMaleMiceMice, Inbred C57BLMicroRNAsPalmitic AcidRatsRats, WistarSTAT3 Transcription FactorGlycolipidsMicroRNAsPalmitic AcidSTAT3 Transcription Factormetabolic disordermicroRNAmiR-125a-5pSTAT3type 2 diabetes mellitus

Identifiers

PMID30555566
PMCPMC6276304
OpenAlexW2903140382

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.